Tsung-Te Chung1,2, Ming-Tsung Lee3,4, Ming-Chou Ku5, Kai-Chieh Yang2, Cheng-Yu Wei6. 1. Department of Otolaryngology, Show Chwan Memorial Hospital, Changhua 500, Taiwan. 2. Sleep Center, Chang Bing Show Chwan Memorial Hospital, Changhua 505, Taiwan. 3. Research Assistant Center, Show Chwan Memorial Hospital, Changhua 500, Taiwan. 4. Department of Nursing, Hungkuang University, Taichung 433, Taiwan. 5. Department of Orthopedics, Show Chwan Memorial Hospital, Changhua 500, Taiwan. 6. Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei 111, Taiwan.
Abstract
OBJECTIVE: Untreated obstructive sleep apnea syndrome (OSAS) increases the risk of cardiovascular, dementia, and motor vehicle accident events. However, continuous positive airway pressure (CPAP) which is the gold standard treatment is not acceptable for many patients with OSAS. Development of devices for the patients of nonadherence to CPAP is necessary. MATERIALS AND METHODS: We evaluated the effect of the smart antisnore pillow (SAP) in patients with OSAS in a prospective, noncontrolled, nonrandomized, pilot study. According to the apnea-hypopnea index (AHI), they were divided into two groups: mild-to-moderate OSAS group and severe OSAS group. Single-night polysomnography (PSG) with application of a SAP was performed. Thirty patients, 15 males and 15 females, 33-82 years old (mean age, 59.3 ± 12.9 years), completed the smart antisnore pillow therapy test. Among them, 23 patients had mild-to-moderate OSAS. RESULTS: The SAP significantly improved the snore number (p = 0.018), snore index (p = 0.013), oxygen denaturation index (p = 0.001), total AHI (p = 0.002), and supine AHI (p = 0.002) in the mild-to-moderate OSAS group, but there was no significant improvement in the severe OSAS group. CONCLUSIONS: We concluded that the SAP is an effective positional therapy device for patients with OSAS of mild-to-moderate severity.
OBJECTIVE: Untreated obstructive sleep apnea syndrome (OSAS) increases the risk of cardiovascular, dementia, and motor vehicle accident events. However, continuous positive airway pressure (CPAP) which is the gold standard treatment is not acceptable for many patients with OSAS. Development of devices for the patients of nonadherence to CPAP is necessary. MATERIALS AND METHODS: We evaluated the effect of the smart antisnore pillow (SAP) in patients with OSAS in a prospective, noncontrolled, nonrandomized, pilot study. According to the apnea-hypopnea index (AHI), they were divided into two groups: mild-to-moderate OSAS group and severe OSAS group. Single-night polysomnography (PSG) with application of a SAP was performed. Thirty patients, 15 males and 15 females, 33-82 years old (mean age, 59.3 ± 12.9 years), completed the smart antisnore pillow therapy test. Among them, 23 patients had mild-to-moderate OSAS. RESULTS: The SAP significantly improved the snore number (p = 0.018), snore index (p = 0.013), oxygen denaturation index (p = 0.001), total AHI (p = 0.002), and supine AHI (p = 0.002) in the mild-to-moderate OSAS group, but there was no significant improvement in the severe OSAS group. CONCLUSIONS: We concluded that the SAP is an effective positional therapy device for patients with OSAS of mild-to-moderate severity.
Authors: Lawrence J Epstein; David Kristo; Patrick J Strollo; Norman Friedman; Atul Malhotra; Susheel P Patil; Kannan Ramar; Robert Rogers; Richard J Schwab; Edward M Weaver; Michael D Weinstein Journal: J Clin Sleep Med Date: 2009-06-15 Impact factor: 4.062
Authors: Rohit Budhiraja; Clete A Kushida; Deborah A Nichols; James K Walsh; Richard D Simon; Daniel J Gottlieb; Stuart F Quan Journal: Eur Respir J Date: 2017-11-30 Impact factor: 16.671
Authors: Syed Fayyaz Hussain; Muhammad Irfan; Zeeshan Waheed; Naveen Alam; Saba Mansoor; Muhammad Islam Journal: BMC Pulm Med Date: 2014-11-29 Impact factor: 3.317
Authors: Vasileios T Stavrou; Yiannis Koutedakis; Kyriaki Astara; George D Vavougios; Eirini Papayianni; Ilias T Stavrou; Fotini Bardaka; Chaido Pastaka; Konstantinos I Gourgoulianis Journal: Front Med (Lausanne) Date: 2022-03-09